
The study revealed IL-34's Role in Cancer Therapeutic Resistance. Scientists Unveil Mechanism of IL-34-Induced Resistance to Anti-Cancer Therapies. Using flow cytometry and IF staining, immune cell changes in the tumor microenvironment were detected after radiation and oxaliplatin treatments. IL-34 was identified as a key factor in immunological changes. Potential for IL-34 blockade as a promising cancer combination therapy
Like
Save
Share